Abstract
Fibromyalgia and chronic widespread pain syndromes are among the commonest diseases seen in rheumatology practice. Despite advances in the management of these conditions, they remain significant causes of morbidity and disability. Autoimmune thyroid disease is the most prevalent autoimmune disorder, affecting about 10 % of the population, and is a recognized cause of fibromyalgia and chronic widespread pain. Recent reports are shedding light on the mechanisms of pain generation in autoimmune thyroid disease-associated pain syndromes including the role of inflammatory mediators, small-fiber polyneuropathy, and central sensitization. The gradual elucidation of these pain pathways is allowing the rational use of pharmacotherapy in the management of chronic widespread pain in autoimmune thyroid disease. This review looks at the current understanding of the prevalence of pain syndromes in autoimmune thyroid disease, their likely causes, present appreciation of the pathogenesis of chronic widespread pain, and how our knowledge can be used to find lasting and effective treatments for the pain syndromes associated with autoimmune thyroid disease.
Similar content being viewed by others
References
Vanhoof J, Declerck K, Geusens P (2002) Prevalence of rheumatic diseases in a rheumatological outpatient practice. Ann Rheum Dis 61:453–455
Branco JC, Bannwarth B, Failde I et al (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39:448–453
Schaefer C, Chandran A, Hufstader M et al (2011) The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes 9:71
Spaeth M (2009) Epidemiology, costs, and the economic burden of fibromyalgia. Arthritis Res Ther 11:117
Howard KJ, Mayer TG, Neblett R, Perez Y, Cohen H, Gatchel RJ (2010) Fibromyalgia syndrome in chronic disabling occupational musculoskeletal disorders: prevalence, risk factors, and posttreatment outcomes. J Occup Environ Med 52:1186–1191
Stathatos N, Daniels GH (2012) Autoimmune thyroid disease. Curr Opin Rheumatol 24:70–75
Weetman AP (2003) Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 148:1–9
Czarnocka B (2011) Thyroperoxidase, thyroglobulin, Na(+)/I(−) symporter, pendrin in thyroid autoimmunity. Front Biosci (Landmark Ed) 16:783–802
Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. N Engl J Med 348:2646–2655
Carette S, Lefrancois L (1988) Fibrositis and primary hypothyroidism. J Rheumatol 15:1418–1421
Kato K, Sullivan PF, Evengard B, Pedersen NL (2006) Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 166:1649–1654
Becker KL, Ferguson RH, Mc CW (1963) The connective-tissue diseases and symptoms associated with Hashimoto’s thyroiditis. N Engl J Med 268:277–280
Golding DN (1970) Hypothyroidism presenting with musculoskeletal symptoms. Ann Rheum Dis 29:10–14
Wilke WS, Sheeler LR, Makarowski WS (1981) Hypothyroidism with presenting symptoms of fibrositis. J Rheumatol 8:626–631
Bland JH, Frymoyer JW, Newberg AH, Revers R, Norman RJ (1979) Rheumatic syndromes in endocrine disease. Semin Arthritis Rheum 9:23–65
Gillan MM, Scofield RH, Harley JB (2002) Hashimoto’s thyroiditis presenting as bilateral knee arthropathy. J Okla State Med Assoc 95:323–325
Kloppenburg M, Dijkmans BA, Rasker JJ (1993) Effect of therapy for thyroid dysfunction on musculoskeletal symptoms. Clin Rheumatol 12:341–345
Golding DN (1993) Rheumatism and the thyroid. J R Soc Med 86:130–132
Aarflot T, Bruusgaard D (1996) Association between chronic widespread musculoskeletal complaints and thyroid autoimmunity. Results from a community survey. Scand J Prim Health Care 14:111–115
Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172
Bazzichi L, Rossi A, Giuliano T et al (2007) Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol 26:2115–2120
Bazzichi L, Rossi A, Zirafa C et al (2012) Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatol Int 32:335–341
Pamuk ON, Cakir N (2007) The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms. Clin Rheumatol 26:55–59
Suk JH, Lee JH, Kim JM (2012) Association between thyroid autoimmunity and fibromyalgia. Exp Clin Endocrinol Diabetes 120:401–404
Ribeiro LS, Proietti FA (2004) Interrelations between fibromyalgia, thyroid autoantibodies, and depression. J Rheumatol 31:2036–2040
Wolfe F, Brahler E, Hinz A, Hauser W (2013) Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken) 65:777–785
Soy M, Guldiken S, Arikan E, Altun BU, Tugrul A (2007) Frequency of rheumatic diseases in patients with autoimmune thyroid disease. Rheumatol Int 27:575–577
Tagoe CE, Zezon A, Khattri S, Castellanos P (2013) Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients. Rheumatol Int 33:1745–1752
Biro E, Szekanecz Z, Czirjak L et al (2006) Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 25:240–245
Boelaert K, Newby PR, Simmonds MJ et al (2010) Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 123:183, e1-9
Cho JH, Gregersen PK (2011) Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 365:1612–1623
Lazurova I, Benhatchi K, Rovensky J et al (2009) Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis. Ann N Y Acad Sci 1173:211–216
Buskila D, Sarzi-Puttini P (2008) Fibromyalgia and autoimmune diseases: the pain behind autoimmunity. Isr Med Assoc J 10:77–78
Koroschetz J, Rehm SE, Gockel U et al (2011) Fibromyalgia and neuropathic pain—differences and similarities. A comparison of 3,057 patients with diabetic painful neuropathy and fibromyalgia. BMC Neurol 11:55
Oaklander AL, Herzog ZD, Downs HM, Klein MM (2013) Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain
Orstavik K, Norheim I, Jorum E (2006) Pain and small-fiber neuropathy in patients with hypothyroidism. Neurology 67:786–791
Molina F, Bouanani M, Pau B, Granier C (1996) Characterization of the type-1 repeat from thyroglobulin, a cysteine-rich module found in proteins from different families. Eur J Biochem 240:125–133
Malthiery Y, Marriq C, Berge-Lefranc JL et al (1989) Thyroglobulin structure and function: recent advances. Biochimie 71:195–209
Mori N, Itoh N, Salvaterra PM (1987) Evolutionary origin of cholinergic macromolecules and thyroglobulin. Proc Natl Acad Sci U S A 84:2813–2817
Weetman AP, Tse CK, Randall WR, Tsim KW, Barnard EA (1988) Acetylcholinesterase antibodies and thyroid autoimmunity. Clin Exp Immunol 71:96–99
Desmeules JA, Cedraschi C, Rapiti E et al (2003) Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 48:1420–1429
Watkins LR, Milligan ED, Maier SF (2001) Glial activation: a driving force for pathological pain. Trends Neurosci 24:450–455
Watkins LR, Maier SF (2005) Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 257:139–155
Bellato E, Marini E, Castoldi F et al (2012) Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012:426130
Mohacsik P, Zeold A, Bianco AC, Gereben B (2011) Thyroid hormone and the neuroglia: both source and target. J Thyroid Res 2011:215718
Martinez-Lavin M (2013) Small fibre neuropathy, fibromyalgia and dorsal root ganglia sodium channels. Brain 136:e246
Kawakami M, Tamaki T, Matsumoto T, Kuribayashi K, Takenaka T, Shinozaki M (2000) Role of leukocytes in radicular pain secondary to herniated nucleus pulposus. Clin Orthop Relat Res 268–277
Podolecki T, Podolecki A, Hrycek A (2009) Fibromyalgia: pathogenetic, diagnostic and therapeutic concerns. Pol Arch Med Wewn 119:157–161
Kidd BL, Urban LA (2001) Mechanisms of inflammatory pain. Br J Anaesth 87:3–11
Tagoe CE, Zezon A, Khattri S (2012) Rheumatic manifestations of autoimmune thyroid disease: the other autoimmune disease. J Rheumatol 39:1125–1129
Lee YC (2013) Effect and treatment of chronic pain in inflammatory arthritis. Curr Rheumatol Rep 15:300
Xiao Y, Haynes WL, Michalek JE, Russell IJ (2013) Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate. Rheumatol Int 33:1259–1264
Kaklamanos M, Thomas D, Pikazis D, Christaki S, Kaltsas G (2013) The effect of rituximab on thyroid function and autoimmunity. Thyroid 23:1044–1045
Raterman HG, Jamnitski A, Lems WF et al (2011) Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study. J Rheumatol 38:247–251
Atzeni F, Doria A, Ghirardello A et al (2008) Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective long-term follow-up. Autoimmunity 41:87–91
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmad, J., Tagoe, C.E. Fibromyalgia and chronic widespread pain in autoimmune thyroid disease. Clin Rheumatol 33, 885–891 (2014). https://doi.org/10.1007/s10067-014-2490-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2490-9